Evidence map›Paper›PMID 33777943›Full record

ArticleFrontiers in cell and developmental biology2021

EGF Induces Migration Independent of EMT or Invasion in A549 Lung Adenocarcinoma Cells.

Karin Schelch, Lisa Vogel, Anja Schneller, Jelena Brankovic, Thomas Mohr, Rupert L Mayer, Astrid Slany, Christopher Gerner, Michael Grusch

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Non-small cell lung cancer map and analysis: exploring interconnected oncogenic signal integrators.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Visualization of the binding between gintonin, aJournal of ginseng research · 2022
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Karin SchelchInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Lisa VogelInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Anja SchnellerInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Jelena BrankovicInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Thomas MohrInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Rupert L MayerDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
Astrid SlanyDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
Christopher GernerDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
Michael GruschInstitute of Cancer Research, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATUniversity of Vienna · AT

Funding

Austrian Science Fund FWF T 1062
6 · The paper itself

Abstract

Tumors and the tumor microenvironment produce multiple growth factors that influence cancer cell behavior via various signal transduction pathways. Growth factors, like transforming growth factor β (TGFβ) and epidermal growth factor (EGF), have been shown to induce proliferation, migration, and invasion in different cell models. Both factors are frequently overexpressed in cancer and will often act in combination. Although both factors are being used as rational targets in clinical oncology, the similarities and differences of their contributions to cancer cell migration and invasion are not fully understood. Here we compared the impact of treating A549 lung adenocarcinoma cells with TGFβ, EGF, and both in combination by applying videomicroscopy, functional assays, immunoblotting, real-time PCR, and proteomics. Treatment with both factors stimulated A549 migration to a similar extent, but with different kinetics. The combination had an additive effect. EGF-induced migration depended on activation of the mitogen-activated protein kinase (MAPK) pathway. However, this pathway was dispensable for TGFβ-induced migration, despite a strong activation of this pathway by TGFβ. Proteome analysis (data are available via ProteomeXchange with identifier PXD023024) revealed an overlap in expression patterns of migration-related proteins and associated gene ontology (GO) terms by TGFβ and EGF. Further, only TGFβ induced the expression of epithelial to mesenchymal transition (EMT)-related proteins like matrix metalloproteinase 2 (MMP2). EGF, in contrast, made no major contribution to EMT marker expression on either the protein or the transcript level. In line with these expression patterns, TGFβ treatment significantly increased the invasive capacity of A549 cells, while EGF treatment did not. Moreover, the addition of EGF failed to enhance TGFβ-induced invasion. Overall, these data suggest that TGFβ and EGF can partly compensate for each other for stimulation of cell migration, but abrogation of TGFβ signaling may be more suitable to suppress cell invasion.

Indexed as

cell migrationEGFepithelial to mesenchymal transitionlung cancerTGFβ

Identifiers

PMID33777943
PMCPMC7994520
OpenAlexW3136290215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.